Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Bibliografske podrobnosti
Main Authors:	Fernandez-Mercado, M, Pellagatti, A, Perry, J, Fernandez-Santamaria, C, Calasanz, M, Larrayoz, M, Odero, MD, Killick, S, Wainscoat, J, Boultwood, J
Format:	Conference item
Izdano:	2010

Podobne knjige/članki

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
od: Boultwood, J, et al.
Izdano: (2010)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
od: Boultwood, J, et al.
Izdano: (2009)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia
od: Pellagatti, A, et al.
Izdano: (2014)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.
od: Pellagatti, A, et al.
Izdano: (2014)

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
od: Boultwood, J, et al.
Izdano: (2010)

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
od: Boultwood, J, et al.
Izdano: (2010)

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics
od: Fernandez-Mercado, M, et al.
Izdano: (2012)

Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia
od: Ana Valencia-Martinez, et al.
Izdano: (2017-09-01)

Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia
od: Moritz Binder, et al.
Izdano: (2022-03-01)

TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia
od: Pérez, C, et al.
Izdano: (2012)

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
od: Marta Fernandez-Mercado, et al.
Izdano: (2012-01-01)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
od: Watkins, F, et al.
Izdano: (2004)

Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia
od: Sarah Abu Kar, et al.
Izdano: (2013-01-01)

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells
od: Davies, C, et al.
Izdano: (2013)

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells.
od: Davies, C, et al.
Izdano: (2013)

Decitabine/Cedazuridine in the Management of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia in Canada
od: John Paul Yun, et al.
Izdano: (2023-08-01)

Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults
od: Dan P. Zandberg, et al.
Izdano: (2013-04-01)

P709: H2AK119UB IN THE TRANSCRIPTIONAL REGULATION OF PATIENTS WITH ASXL1-MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA
od: Moritz Binder, et al.
Izdano: (2023-08-01)

Gene expression profiling in the myelodysplastic syndromes.
od: Pellagatti, A, et al.
Izdano: (2005)

Acute Myeloid Leukemia with Co-mutated ASXL1 and SRSF2 Exhibits Monocytic Differentiation and has a Mutational Profile Overlapping with Chronic Myelomonocytic Leukemia
od: Steven M. Johnson, et al.
Izdano: (2019-10-01)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
od: Fernandez-Mercado, M, et al.
Izdano: (2013)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
od: Fernandez-Mercado, M, et al.
Izdano: (2013)

TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia.
od: Cristina Pérez, et al.
Izdano: (2012-01-01)

PB2022: ELTROMBOPAG IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA: A SINGLE-CENTER EXPERIENCE
od: Amaia Lopez Peña, et al.
Izdano: (2023-08-01)

Cytogenetic risk stratification in chronic myelomonocytic leukemia
od: Esperanza Such, et al.
Izdano: (2011-03-01)

<i>ASXL1/TET2</i> genotype-based risk stratification outperforms <i>ASXL1</i> mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia
od: Clifford M. Csizmar, et al.
Izdano: (2024-06-01)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
od: Pellagatti, A, et al.
Izdano: (2008)

The prognostic value of the interaction between ASXL1 and TET2 gene mutations in patients with chronic myelomonocytic leukemia: a meta-analysis
od: Wenxia Zhao, et al.
Izdano: (2022-12-01)

Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
od: Liqing Yang, et al.
Izdano: (2024-01-01)

Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia
od: Vincent Jachiet, et al.
Izdano: (2021-02-01)

Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts
od: Véronique Gelsi-Boyer, et al.
Izdano: (2013-04-01)

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
od: Olivier Kosmider, et al.
Izdano: (2009-12-01)

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of <it>RAS </it>and <it>RUNX1 </it>genes
od: Olschwang Sylviane, et al.
Izdano: (2008-10-01)

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.
od: Li-Hong Shou, et al.
Izdano: (2017-01-01)

Azacitidine Treatment in Patients with Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Type 2 and Acute Myeloid Leukemia According to their Cytogenetic Findings
od: Nikolova D., et al.
Izdano: (2021-10-01)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
od: Fernandez-Mercado, M, et al.
Izdano: (2013)

Clonality in the myelodysplastic syndromes.
od: Boultwood, J, et al.
Izdano: (2001)

Molecular basis of juvenile myelomonocytic leukemia
od: Andrica C.H. de Vries, et al.
Izdano: (2010-02-01)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, et al.
Izdano: (2009)

Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase
od: Emmanuella Oyogoa, et al.
Izdano: (2023-09-01)